Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $93.94M.
ENTERPRISE VALUE (EV)
$93.94M
Protara Therapeutics, Inc.
Market Cap
$143.60M
Enterprise Value (EV)
$93.94M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Protara Therapeutics, Inc. (TARA) | $143.60M | $93.94M |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | $82.64M |
| Nyxoah S.A. (NYXH)vs › | $143.10M | $129.92M |
| Fortress Biotech, Inc. (FBIOP)vs › | $146.27M | $14.47M |
| Codexis, Inc. (CDXS)vs › | $146.28M | $191.70M |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | $118.75M |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | $96.28M |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | $98.09M |
| Immuneering Corporation (IMRX)vs › | $139.04M | $101.35M |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | $29.95M |
Market Cap
$143.60M
Total Debt
$0.00
Cash
$49.66M
Enterprise Value
$93.94M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
